Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study.

Peter Ueda Viktor Wintzell Mads Melbye Bjorn Eliasson Ann-Marie Svensson Stefan Franzen Soffia Gudbjörnsdottir Kristian Hveem Christian Jonasson Henrik Svanström Björn Pasternak

Published in: Diabetologia (2021)

In this analysis using nationwide data from three countries, use of DPP4 inhibitors and GLP-1-receptor agonists, compared with sulfonylureas, was not associated with a significantly increased risk of cholangiocarcinoma.

Keyphrases

electronic health record
big data
cross sectional
machine learning
data analysis
deep learning